How much does Vyndaqel (Tafamidis Meglumine Soft Capsules) Cost& price without insurance in China?
Vyndaqel® is the commercial brand name of Tafamidis Meglumine Soft Capsules, an orally active transthyretin stabilizer developed by Pfizer. It binds to transthyretin protein to stabilize its tetrameric structure, inhibit abnormal protein dissociation and amyloid deposition, thereby slowing disease progression of transthyretin amyloidosis.
Main Indications
Treatment of adult patients with transthyretin amyloid cardiomyopathy (ATTR-CM), including wild-type and hereditary transthyretin amyloid cardiomyopathy;
Treatment of adult patients with transthyretin amyloid polyneuropathy (ATTR-PN) in early symptomatic stage.
Common Side Effects
Common mild adverse reactions: Diarrhea, upper abdominal pain, nausea, vomiting and fatigue.
Laboratory abnormalities: Mild elevated hepatic transaminases.
Severe but manageable risks: Severe liver injury and hypersensitivity reactions.
Approval Status in China
Vyndaqel® (Tafamidis Meglumine Soft Capsules, 20mg, domestic trade name: Weidaquan) was officially approved for marketing in China in 2020. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Vyndaqel (Tafamidis Meglumine Soft Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
